Lateral Flow Assays Market Size and Share Analysis by Product, Application, Technique, Sample Type, End User

Description

In 2023, the lateral flow assays market amounted to USD 22.0 billion and is set to grow at a compound annual growth rate of 2.1% between 2024 and 2030 reaching an estimated amount of USD 25.4 billion by 2030.

This development of the market can be credited to the increasing occurrence of communicable syndromes, the rising need for point-of-care testing, the rising elderly populace, the growing utilization of home-based lateral flow assay devices, the increasing requirement for efficient diagnostic methods, and the growing government initiatives motivating health awareness.

Presently, the mainstream of diagnostic test procedures is lab-based throughout the globe. Thus, there is a quick increase in the acceptance of POC testing based on lateral flow assays, to substitute time-taking conservative lab test procedures.

Because of the utilization of these assays, POC testing is fast, easy, low-priced, simple to interpret, and suitable. Also, the price of test procedures is less than orthodox tests, and they do not require complex infrastructure and training. Therefore, such reasons are subsequently boosting the growth and demand for such assays.

In 2023, the kits and reagents category grip a higher share for lateral flow assays, on the basis of product segment. This development can be ascribed to the increasing count of application areas of lateral flow kits and reagents for point-of-care testing, the rising occurrence of chronic syndromes, and the rising utilization of lateral flow kits in housing care, credited to their simple, comfortable, and suitable advantages.

The sandwich assays category had the largest revenue share, around 50%, in 2023. This is mainly credited to the advanced specificity and sensitivity of such assays for greater analytes that have two epitopes or binding sites.

The most often type of commercially paper-based biosensors is sandwiching lateral flow assays that provide an inexpensive, precise, fast, and single-step assay. For example, the sandwich-based assay can offer outcomes in just 10 minutes and can be used in low-resource healthcare amenities without requiring the aid of trained medicinal professionals.

The North American market, which accounts for 45% of revenue in 2023, is the largest worldwide LFF assay market. This is due to the increased incidences of COVID-19, Lyme disease, and tuberculosis, and a rise in mortality rates related to HIV and AIDS in the region.

In the US, according to government statistics, around 1.2 million people are infected in October 2022 and an estimated 13% don't know what it is or need testing.

The U.S. had the larger revenue share in the North American industry. This is because of the increasing pool of patients suffering from diseases and high affordability with rising per-capita income.

Product Code: 12727

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by technique
- 1.4.4. Market size breakdown, by sample type
- 1.4.5. Market size breakdown, by end user
- 1.4.6. Market size breakdown, by region
- 1.4.7. Market size breakdown, by country
1.5. Market Data Reporting Unit
- 1.5.1. Value
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview
6.2. Market Revenue, by Product (2017-2030)
6.3. Market Revenue, by Application (2017-2030)
- 6.3.1. Clinical testing market revenue, by type (2017-2030)
6.4. Market Revenue, by Technique (2017-2030)
6.5. Market Revenue, by Sample Type (2017-2030)
6.6. Market Revenue, by End User (2017-2030)
6.7. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

7.1. Overview
7.2. Market Revenue, by Product (2017-2030)
7.3. Market Revenue, by Application (2017-2030)
- 7.3.1. Clinical testing market revenue, by type (2017-2030)
7.4. Market Revenue, by Technique (2017-2030)
7.5. Market Revenue, by Sample Type (2017-2030)
7.6. Market Revenue, by End User (2017-2030)
7.7. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

8.1. Overview
8.2. Market Revenue, by Product (2017-2030)
8.3. Market Revenue, by Application (2017-2030)
- 8.3.1. Clinical testing market revenue, by type (2017-2030)
8.4. Market Revenue, by Technique (2017-2030)
8.5. Market Revenue, by Sample Type (2017-2030)
8.6. Market Revenue, by End User (2017-2030)
8.7. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

9.1. Overview
9.2. Market Revenue, by Product (2017-2030)
9.3. Market Revenue, by Application (2017-2030)
- 9.3.1. Clinical testing market revenue, by type (2017-2030)
9.4. Market Revenue, by Technique (2017-2030)
9.5. Market Revenue, by Sample Type (2017-2030)
9.6. Market Revenue, by End User (2017-2030)
9.7. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

10.1. Overview
10.2. Market Revenue, by Product (2017-2030)
10.3. Market Revenue, by Application (2017-2030)
- 10.3.1. Clinical testing market revenue, by type (2017-2030)
10.4. Market Revenue, by Technique (2017-2030)
10.5. Market Revenue, by Sample Type (2017-2030)
10.6. Market Revenue, by End User (2017-2030)
10.7. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

11.1. Overview
11.2. Market Revenue, by Product (2017-2030)
11.3. Market Revenue, by Application (2017-2030)
- 11.3.1. Clinical testing market revenue, by type (2017-2030)
11.4. Market Revenue, by Technique (2017-2030)
11.5. Market Revenue, by Sample Type (2017-2030)
11.6. Market Revenue, by End User (2017-2030)
11.7. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

12.1. Overview
12.2. Market Revenue, by Product (2017-2030)
12.3. Market Revenue, by Application (2017-2030)
- 12.3.1. Clinical testing market revenue, by type (2017-2030)
12.4. Market Revenue, by Technique (2017-2030)
12.5. Market Revenue, by Sample Type (2017-2030)
12.6. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

13.1. Overview
13.2. Market Revenue, by Product (2017-2030)
13.3. Market Revenue, by Application (2017-2030)
- 13.3.1. Clinical testing market revenue, by type (2017-2030)
13.4. Market Revenue, by Technique (2017-2030)
13.5. Market Revenue, by Sample Type (2017-2030)
13.6. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

14.1. Overview
14.2. Market Revenue, by Product (2017-2030)
14.3. Market Revenue, by Application (2017-2030)
- 14.3.1. Clinical testing market revenue, by type (2017-2030)
14.4. Market Revenue, by Technique (2017-2030)
14.5. Market Revenue, by Sample Type (2017-2030)
14.6. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

15.1. Overview
15.2. Market Revenue, by Product (2017-2030)
15.3. Market Revenue, by Application (2017-2030)
- 15.3.1. Clinical testing market revenue, by type (2017-2030)
15.4. Market Revenue, by Technique (2017-2030)
15.5. Market Revenue, by Sample Type (2017-2030)
15.6. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

16.1. Overview
16.2. Market Revenue, by Product (2017-2030)
16.3. Market Revenue, by Application (2017-2030)
- 16.3.1. Clinical testing market revenue, by type (2017-2030)
16.4. Market Revenue, by Technique (2017-2030)
16.5. Market Revenue, by Sample Type (2017-2030)
16.6. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

17.1. Overview
17.2. Market Revenue, by Product (2017-2030)
17.3. Market Revenue, by Application (2017-2030)
- 17.3.1. Clinical testing market revenue, by type (2017-2030)
17.4. Market Revenue, by Technique (2017-2030)
17.5. Market Revenue, by Sample Type (2017-2030)
17.6. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

18.1. Overview
18.2. Market Revenue, by Product (2017-2030)
18.3. Market Revenue, by Application (2017-2030)
- 18.3.1. Clinical testing market revenue, by type (2017-2030)
18.4. Market Revenue, by Technique (2017-2030)
18.5. Market Revenue, by Sample Type (2017-2030)
18.6. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

19.1. Overview
19.2. Market Revenue, by Product (2017-2030)
19.3. Market Revenue, by Application (2017-2030)
- 19.3.1. Clinical testing market revenue, by type (2017-2030)
19.4. Market Revenue, by Technique (2017-2030)
19.5. Market Revenue, by Sample Type (2017-2030)
19.6. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

20.1. Overview
20.2. Market Revenue, by Product (2017-2030)
20.3. Market Revenue, by Application (2017-2030)
- 20.3.1. Clinical testing market revenue, by type (2017-2030)
20.4. Market Revenue, by Technique (2017-2030)
20.5. Market Revenue, by Sample Type (2017-2030)
20.6. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

21.1. Overview
21.2. Market Revenue, by Product (2017-2030)
21.3. Market Revenue, by Application (2017-2030)
- 21.3.1. Clinical testing market revenue, by type (2017-2030)
21.4. Market Revenue, by Technique (2017-2030)
21.5. Market Revenue, by Sample Type (2017-2030)
21.6. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

22.1. Overview
22.2. Market Revenue, by Product (2017-2030)
22.3. Market Revenue, by Application (2017-2030)
- 22.3.1. Clinical testing market revenue, by type (2017-2030)
22.4. Market Revenue, by Technique (2017-2030)
22.5. Market Revenue, by Sample Type (2017-2030)
22.6. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

23.1. Overview
23.2. Market Revenue, by Product (2017-2030)
23.3. Market Revenue, by Application (2017-2030)
- 23.3.1. Clinical testing market revenue, by type (2017-2030)
23.4. Market Revenue, by Technique (2017-2030)
23.5. Market Revenue, by Sample Type (2017-2030)
23.6. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

24.1. Overview
24.2. Market Revenue, by Product (2017-2030)
24.3. Market Revenue, by Application (2017-2030)
- 24.3.1. Clinical testing market revenue, by type (2017-2030)
24.4. Market Revenue, by Technique (2017-2030)
24.5. Market Revenue, by Sample Type (2017-2030)
24.6. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

25.1. Overview
25.2. Market Revenue, by Product (2017-2030)
25.3. Market Revenue, by Application (2017-2030)
- 25.3.1. Clinical testing market revenue, by type (2017-2030)
25.4. Market Revenue, by Technique (2017-2030)
25.5. Market Revenue, by Sample Type (2017-2030)
25.6. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

26.1. Overview
26.2. Market Revenue, by Product (2017-2030)
26.3. Market Revenue, by Application (2017-2030)
- 26.3.1. Clinical testing market revenue, by type (2017-2030)
26.4. Market Revenue, by Technique (2017-2030)
26.5. Market Revenue, by Sample Type (2017-2030)
26.6. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

27.1. Overview
27.2. Market Revenue, by Product (2017-2030)
27.3. Market Revenue, by Application (2017-2030)
- 27.3.1. Clinical testing market revenue, by type (2017-2030)
27.4. Market Revenue, by Technique (2017-2030)
27.5. Market Revenue, by Sample Type (2017-2030)
27.6. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

28.1. Overview
28.2. Market Revenue, by Product (2017-2030)
28.3. Market Revenue, by Application (2017-2030)
- 28.3.1. Clinical testing market revenue, by type (2017-2030)
28.4. Market Revenue, by Technique (2017-2030)
28.5. Market Revenue, by Sample Type (2017-2030)
28.6. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings
29.2. Competitive Benchmarking of Key Players
29.3. Product Benchmarking of Key Players
29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Abbott Laboratories
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
30.2. Thermo Fisher Scientific Inc.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
30.3. F. Hoffmann-La Roche Ltd.
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
30.4. Bio-Rad Laboratories Inc.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
30.5. Siemens Healthineers GmbH
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
30.6. QuidelOrtho Corporation
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
30.7. Hologic Inc.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
30.8. PerkinElmer Inc.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
30.9. QIAGEN N.V.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
30.10. Becton, Dickinson and Company
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
30.11. Danaher Corporation
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.11.3. Key financial summary
30.12. BIOMERIEUX SA
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.12.3. Key financial summary
30.13. Surmodics Inc.
- 30.13.1. Business overview
- 30.13.2. Product and service offerings
- 30.13.3. Key financial summary
30.14. Chembio Diagnostics Inc.
- 30.14.1. Business overview
- 30.14.2. Product and service offerings
- 30.14.3. Key financial summary
30.15. OraSure Technologies Inc.
- 30.15.1. Business overview
- 30.15.2. Product and service offerings
- 30.15.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations
31.2. Sources and References
31.3. Related Reports

Lateral Flow Assays Market Size and Share Analysis by Product, Application, Technique, Sample Type, End User - Global Industry Demand Forecast to 2030